Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ALA-PDT for Cutaneous Lymphomas and Early CLL
NCT00054171Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Feb 1999
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in cutaneous T-cell lymphoma (CTCL), cutaneous B-cell lymphoma (PCBCL), chronic lymphocytic leukemia (CLL), sponsored by Roswell Park Comprehensive Cancer Center. Started Feb 1999; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
cutaneous T-cell lymphoma (CTCL)cutaneous B-cell lymphoma (PCBCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00054171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054171.